S
Southern Neurology | Sydney, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
SHR-1707
XEN1101
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and toler...
Enrolling
Focal Onset Seizures
Drug: Placebo
Drug: XEN1101
This study is researching the experimental drugs called pozelimab and cemdisiran, and cemdisiran monotherapy. The study is focused on patients with g...
Enrolling
Generalized Myasthenia Gravis
Drug: Pozelimab
Drug: Pozelimab + Cemdisiran
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1707 in patients with mild cognitive impairment (MCI) due to Alzhe...
Active, not recruiting
Alzheimer's Disease (AD)
Drug: SHR-1707 injection
Drug: Placebo
Trial sponsors
A
X
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems